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ABSTRACT. Simhon, A., Yolken, R. H. and Mata, L. (Instituto de Investigations en Salud ( 
INISA), University of Costa Rica, San Jose, Costa Rica). S-IgA cholera toxin and rotavirus 
antibody inhuman colostrum. Acta Paediatr Scand, 68: 161, 1979.—S-1gA antibodies against 
cholera toxin and rotavirus were assayed in 43 colostral samples by means of an enzyme-linked 
immunosorbent assay (ELISA). Ali specimens contained specific S-1gA antibodies against both 
antigens. Significant antibody titres to the antigens were demonstrated In almost all colostral 
samples.
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The aetiology of "non-specific- infantile di-
arrhoea has been further elucidated by recog-
nition of the pathogenic role of enterotoxi-
genic Escherichia colt (5, 12) and rotavirus (1, 
4). The risk of exposure of infants to these 
agents, particularly in developing countries, 
has stimulated study of the protective effect of 
breast-feeding against their infection and as-
sociated diarrhoea.
S-IgA antibodies to enterotoxins of Entero-
bacteriaceae and Vibrio cholerae have been 
described in human milk by neutralisation as-
says and the enzyme-linked immunosorbent 
assay (ELISA) (7, 15). Also, colostra of wom-
en from Costa Rica, Guatemala and the United 
States were found to contain considerable 
amounts of anti-rotavirus antibody (21). This 
report describes a semi-quantitative assay of 
anti-cholera toxin S-IgA antibody by ELISA 
as an alternative to neutralisation techniques. 
Furthermore, additional evidence is presented 
to confirm that colostra from Costa Rican 
women contain significant levels of anti-rota-
virus antibody.
MATERIALS AND METHODS Specimens. 
Colostrum from 43 women aged 16 to 30 
years from San Jose, Costa Rica were b id 
72 hours post-partum. Mothers were of a 
medium-to-low socio-economic status ( 
approximate per capita yearly income, US 
$70-150). All were at least minimally literate. 
S-IgA was assayed by the ELISA (2. 17) in a 
modification developed by Yoiken et al. for 
rotavirus antigen (20), for labile toxin of E. 
calf (19), and for rotavirus antibody assay (21) 
.
ELISA for cholera toxin antibody. 2.5 ng of 
cholera toxin (Schwarz Mann, Inc., 
Orangeburg. N. Y., USA) were added to each 
well of polyvinyl microtitre plates (Cooke 
Engineering Co., Alexandria. Virginia. USA) 
pre-coated with burro anti-cholera toxin 
antibody. Six fourfold dilutions of each 
colostrum sample were added in duplicate 
wells. A conjugate of rabbit anti-secretory 
component (SC) (Dakopatts AS, 
Copenhagen, Denmark) and alkaline 
phosphatase (Sigma Chemical Co, St. Louis, 
Missouri, USA) was then added to each well. 
Addition of p-nitrophenyl phosphate 
substrate produced a yellow colour; the 
reaction was stopped with 3N NaOH and the 
colour was read at 400 nm in a Beckman 
DU-2 Spectrophotometer.
ELISA for rotavirus antibody. The procedure 
described by Yolken et al. (21) allowed 
reaction of a guinea pig anti-rotavirus serum 
with a rotavirus-positive stool filtrate; the 
antigen was obtained by experimental 
infection of a gnotobiotic calf with human 
rotavirus. This technique was modified as 
follows: a 2% suspension of pooled stools 
from Costa Rican children, positive for 
rotavirus by both electron microscopy and 
ELISA, was added to each well of microtitre
to cholera toxin and rotavirus by means of 
blocking tests (20). In order to remove spurious 
antibodies to the various reagents in the tests (i. 
e. immune sera. colostra), those reagents were 
treated as described by Yolken et al. (22). 
Addition of colostrum was omitted in negative 
controls.
ELISA end-point titres. To determine the titre 
of specific S-IgA, positive/negative (P/N) 
values were determined for each colostrum by 
dividing the spectrophotometric absorbance of 
the diluted sample by that of the negative 
control. A P/N value of 2.0 or greater was 
considered confirmatory of the presence of S-
IgA. Reciprocal antibody titres were defined 
as the highest dilution with a P/N value of 2.0 
or greater.
RESULTS
None of the colostral samples contained 
either cholera toxin or rotavirus antigen. The 
anti-SC globulin failed to block otherwise 
positive reactions for cholera toxin and 
rotavirus antigen.
All colostral samples were shown to contain 
S-IgA antibodies to both cholera toxin and 
rotavirus antigen (Table 1). The geometric 
mean titres of anti-cholera toxin and anti-
rota-virus antibodies were 264.4 and 114.3, 
respectively. A scatter diagram of 
reciprocal titres for each colostrum is 
presented in Fig. 1. A positive-correlating 
trend was observed.
of specific S-IgA antibodies against cholera 
toxin. Since there has been no evidence of 
cholera in Costa Rica in this century, it can 
be advanced that the labile toxin of E. coli ( 
or of another Enterobacteriaceae) has been 
the inmunogen eliciting anti-cholera toxin 
antibody. The fact strengthens the 
resemblance or identity of these toxins (6, 
13). Labile toxin (LT) of E. coli was 
demonstrated by passive immune hemolysis 
(3) in 9 % of hospitalized diarrhoeic and 6% 
of non-diarrhoeic Costa Rican children over 
a two-year prospective observation (11). 
Thus, a high exposure to LT is observed in 
Costa Rica which presumably is reflected in 
high antibody titres. Entero-toxin-
neutralising activity was demonstrated in a 
large number of specimens of Guatemalan 
colostrum and Pakistani mature milk, by 
Stoliar et al. (15) and Holmgren et al. (7), 
respectively. Inasmuch neutralisation titres 
were not determined for the Costa Rican 
colostrum, no comparison can be made with 
such findings.
The ELISA geometric mean titre of cholera 
toxin S-IgA in Pakistani milk was 
significantly lower than that of Costa Rican 
colostrum, presumably reflecting differences 
in concentration between milk and colostrum. 
The possibility that differences resulted from 
varying experimental conditions should not
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E. coli heat-labile enterotoxin was 
unavailable in our laboratory so 
commercially purified cholera toxin was 
utilized in this study; antibody end-point 
titres may have been defined differently in 
other studies; also, colostra from women of 
different socio-economic condition may 
yield different results. The present findings 
and those of Yolken et al. (21) reveal 
significant amounts of anti-rotavirus 
antibody in the majority of colostral 
specimens, regardless of geographical 
location. Furthermore, they showed that 
rotavirus antibody persisted to detectable 
levels throughout 24 months of lactation. 
Studies are under way to measure activity in 
terms of units of neutralisation per mg of S-
IgA.
The correlation trend between titres of anti-
cholera toxin and anti-rotavirus antibodies 
suggests a similar exposure or response in in-
dividual mothers to both antigens.
In a model system of human rotavirus in-
fection in lambs (14) passive immunity was 
studied by oral administration of human anti-
rotavirus IgG; clinical manifestations were 
prevented presumably by neutralisation of 
either the initial inoculum or virus subsequent-
ly released by cells, or both. Nosocomial 
outbreaks of rotavirus have been controlled by 
oral administration of colostrum (16). Similar-
ly, exclusively breast-fed Indian neonates and 
young infants of a Guatemalan Mayan village 
exhibited a lower incidence of gastrointestinal 
disorders despite frequent exposure to entero-
pathogens (9, 10).
Regarding anti-cholera factors, protection 
against experimental cholera diarrhoea was 
shown to result from the synergistic action of 
anti-bacterial and anti-toxin antibodies (8) . 
More research is needed to further asess the 
relative protective role of anti-bacterial and 
anti-toxin antibodies. Colostral IgG and IgM 
antibodies, already demonstrated in colostra 
from Central American women (18), also 
may provide added protection against 
enterotoxi-genic and rotavirus infections. 
other virulence factors is of public health sig-
nificance, especially in transitional societies 
now experimenting a decline in breast-
feeding. Moreover, the adequacy of passive 
immunity against toxigenic bacteria and 
rotaviruses must be evaluated in mature milk 
and in the various phases of lactation.
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